Schedule of Impact of Restatement in Company's Condensed Unaudited Consolidated Financial Statements |
The table below present the impact of the restatement in the Company's condensed consolidated unaudited financial statements:
|
|
|
|
|
|
|
|
|
|
For the Three Months ended March 31, 2020
(Unaudited)
|
|
As previously
|
|
Adjustment
|
|
As Restated
|
reported
|
Statement of Operations
|
|
|
|
|
|
Amortization and depreciation
|
$
|
46,676
|
|
$
|
(46,676)
|
|
$
|
-
|
Total Operating Expense
|
$
|
335,472
|
|
$
|
(46,676)
|
|
$
|
288,796
|
Income/(Loss) from continuing operations before income taxes
|
$
|
47,323
|
|
$
|
46,676
|
|
$
|
93,999
|
Net Income/(Loss)
|
$
|
5,813
|
|
$
|
46,676
|
|
$
|
52,489
|
Net Income/(Loss) attributable to common stockholders
|
$
|
(4,418)
|
|
$
|
46,676
|
|
$
|
42,258
|
|
|
|
|
|
|
|
|
|
Net Income/(Loss) per share basic and diluted
|
|
|
|
|
|
|
|
|
Income/(Loss) from continuing operations
|
$
|
0.00
|
|
$
|
0.00
|
|
$
|
0.00
|
Income/(Loss) per common share - basic and diluted
|
$
|
(0.00)
|
|
$
|
0.00
|
|
$
|
0.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Six Months ended March 31, 2020
(Unaudited)
|
|
As previously
|
|
Adjustment
|
|
As Restated
|
reported
|
Statement of Operations
|
|
|
|
|
|
Amortization and depreciation
|
$
|
95,910
|
|
$
|
(85,032)
|
|
$
|
10,878
|
Total Operating Expense
|
$
|
655,830
|
|
$
|
(85,032)
|
|
$
|
570,798
|
Income from continuing operations before income taxes
|
$
|
33,565
|
|
$
|
85,032
|
|
$
|
118,597
|
Net Income/(Loss)
|
$
|
(31,371)
|
|
$
|
85,032
|
|
$
|
53,661
|
Net Income/(Loss) attributable to common stockholders
|
$
|
(51,946)
|
|
$
|
85,032
|
|
$
|
33,086
|
|
|
|
|
|
|
|
|
|
Net Income/(Loss) per share basic and diluted
|
|
|
|
|
|
|
|
|
Income/(Loss) from continuing operations
|
$
|
(0.00)
|
|
$
|
0.00
|
|
$
|
0.00
|
Income/(Loss) per common share - basic and diluted
|
$
|
(0.00)
|
|
$
|
0.00
|
|
$
|
0.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2020
(Unaudited)
|
|
As previously
|
|
Adjustment
|
|
As Restated
|
reported
|
Statement of Changes in Stockholders Deficit
|
|
|
|
|
|
Additional Paid in Capital
|
$
|
15,866,718
|
|
$
|
(600,000)
|
|
$
|
15,266,718
|
Accumulated Deficit
|
$
|
(16,252,481)
|
|
$
|
85,032
|
|
$
|
(16,167,449)
|
Total Stockholders Deficit
|
$
|
(383,436)
|
|
$
|
(514,968)
|
|
$
|
(898,404)
|
Total Liabilities and Stockholders Deficit
|
$
|
753,103
|
|
$
|
(514,968)
|
|
$
|
238,135
|
|
|
|
|
|
|
|
|
|
|
March 31, 2020
(Unaudited)
|
|
As previously
|
|
Adjustment
|
|
As Restated
|
reported
|
Statement of Cash Flow
|
|
|
|
|
|
Net Income/(Loss)
|
$
|
(31,371)
|
|
$
|
85,032
|
|
$
|
53,661
|
Amortization of ReadyMed software platform
|
$
|
85,032
|
|
$
|
(85,032)
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
Common stock issued for ReadyMed platform
|
$
|
600,000
|
|
$
|
(600,000)
|
|
$
|
-
|
|